Plerixafor Impurities
Plerixafor is a bicyclam derivative that acts as a selective antagonist of the CXCR4 chemokine receptor, used in hematopoietic stem cell mobilization for transplantation. Its impurity profile includes structurally related analogs, residual solvents, and degradation products formed under stress conditions such as hydrolysis, oxidation, and photolysis. Furthermore, typical degradation pathways involve oxidative modification of the cyclam rings, hydrolytic cleavage of amine linkages, and rearrangement of substituents within the heteroaromatic scaffold. These impurities may affect the drug’s potency, stability, and safety. Importantly, all impurities are structurally characterized and qualified according to ICH guidelines for toxicological assessment and analytical validation.
Plerixafor EP Impurities
Pharmacopeial and non-pharmacopeial Plerixafor impurity compounds are available in compliance with European Pharmacopoeia (EP) specifications. These standards support analytical method development, impurity profiling, and long-term stability studies. In addition, EP traceable materials are supplied with validated analytical data, including purity, structural confirmation, and spectral characterization.
Plerixafor Related Compounds
Structurally related compounds and synthetic analogs associated with Plerixafor are included for impurity identification, toxicological qualification, and regulatory submission. Consequently, these related substances are used in forced degradation studies, genotoxicity assessments, and impurity threshold evaluations. They are essential for understanding the impurity profile and ensuring compliance with regulatory limits.
Plerixafor Impurity Reference Standards
Plerixafor impurity reference standards are provided with validated analytical data, including purity, NMR, MS, and full Certificates of Analysis. These standards are used in pharmaceutical research, method validation, and GMP-compliant quality control. Additionally, EP/USP traceable entries are available upon request and are routinely re-tested to ensure consistency and reliability.
